Table 1.
Demographic and clinical risk factors of the participants
| Total (N=20,962) | White Men (n=5052) | Black Men (n=2760) | White Women (n=7317) | Black Women (n=5833) |
|---|---|---|---|---|
| Age (years*) | 57.7 (0.04) | 55.7(0.05) | 61.0(0.03) | 58.1(0.03) |
| Systolic blood pressure, (mm Hg) | 123.6(0.40) | 129.5(0.56) | 120.9(0.33) | 127.2(0.35) |
| Body mass index (kg/m2) | 28.5(0.16) | 29.2(0.19) | 28.2(0.13) | 32.0(0.16) |
| Low density lipoprotein-cholesterol (mg/dL) | 113.6 (0.97) | 114.5(1.26) | 114.9(0.68) | 118.0(0.73) |
| High density lipoprotein-cholesterol (,mg/dL) | 45.0(0.37) | 48.8(0.52) | 58.0(0.33) | 56.5(0.31) |
| Triglycerides (mg/dL) | 148.7(3.60) | 119.1(2.36) | 134.2(1.77) | 105.6(1.21) |
| Diabetes mellitus | 885(13.3%) | 795(24.0%) | 904(9.8%) | 1669(23.9%) |
| Current Smoker | 641(13.7%) | 574(26.9%) | 943(13.5%) | 901(19.8%) |
| Treated for Hypertension† | 2690(36.9%) | 1748(50.4%) | 3620(40.7%) | 3978(59.1%) |
| Treated for Hyperlipidemia‡ | 1968(27.2%) | 817(22.2%) | 2052(22.7%) | 1680(22.1%) |
*
Weighted Means (standard error) unless otherwise indicated
‡
Any lipid lowering medication
†
Any antihypertensive medication (diuretic, ace-inhibitor, beta-blocker, calcium-channel blocker, angiotensin converting enzyme inhibitor, alpha-blocker)